Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Neoplasms and CHEK1[original query] |
---|
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Aug 16 (8): 1655-61. Rajaraman Preetha, Wang Sophia S, Rothman Nathaniel, Brown Merideth M, Black Peter M, Fine Howard A, Loeffler Jay S, Selker Robert G, Shapiro William R, Chanock Stephen J, Inskip Peter |
Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Apr 14 (7): 2042-8. Okazaki Taro, Jiao Li, Chang Ping, Evans Douglas B, Abbruzzese James L, Li Dongh |
Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PloS one 2013 8 (7): e68578. Lin Wei-Yu, Brock Ian W, Connley Dan, Cramp Helen, Tucker Rachel, Slate Jon, Reed Malcolm W R, Balasubramanian Sabapathy P, Cannon-Albright Lisa A, Camp Nicola J, Cox Ange |
Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability. PloS one 2017 12 (6): e0178450. Stafford Jaime L, Dyson Gregory, Levin Nancy K, Chaudhry Sophia, Rosati Rita, Kalpage Hasini, Wernette Courtney, Petrucelli Nancie, Simon Michael S, Tainsky Michael |
Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database. Journal of cellular biochemistry 2017 May . Liu Chang, Chang Hong, Li Xiao-Han, Qi Ya-Fei, Wang Jin-Ou, Zhang Ying, Yang Xiang-Ho |
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 1015-1022. Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Murgioni S, Rossini D, Marmorino F, Mennitto A, Ning Y, Okazaki S, Berger M D, Miyamoto Y, Gopez R, Barzi A, Yamaguchi T, Loupakis F, Lenz H |
Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population. Oncotarget 2018 Jun 9 (42): 26616-26624. Wang Shijia, Zhang Yue, Chen Min, Wang Yong, Feng Yifei, Xu Ziwei, Zhang Dongsheng, Sun Yueming, Fu Z |
Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Oncotarget 2018 Apr 9 (28): 19817-19825. Kondo Tomohiro, Kanai Masashi, Kou Tadayuki, Sakuma Tomohiro, Mochizuki Hiroaki, Kamada Mayumi, Nakatsui Masahiko, Uza Norimitsu, Kodama Yuzo, Masui Toshihiko, Takaori Kyoichi, Matsumoto Shigemi, Miyake Hidehiko, Okuno Yasushi, Muto Mana |
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations. JCO precision oncology 2019 9 3 . Dumbrava E Ileana, Brusco L, Daniels M, Wathoo C, Shaw K, Lu K, Zheng X, Strong L, Litton J, Arun B, Eterovic A K, Routbort M, Patel K, Qi Yuan, Piha-Paul S, Subbiah V, Hong D, Rodon J, Kopetz S, Mendelsohn J, Mills G B, Chen K, Meric-Bernstam |
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy. The oncologist 2019 5 24 (10): 1340-1347. Parikh Aparna R, He Yuting, Hong Ted S, Corcoran Ryan B, Clark Jeff W, Ryan David P, Zou Lee, Ting David T, Catenacci Daniel V, Chao Joseph, Fakih Marwan, Klempner Samuel J, Ross Jeffrey S, Frampton Garrett M, Miller Vincent A, Ali Siraj M, Schrock Alexa |
Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors. Cancers 2020 3 12 (3): . Fadaka Adewale Oluwaseun, Bakare Olalekan Olanrewaju, Sibuyi Nicole Remaliah Samantha, Klein Ashw |
Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach. International journal of radiation oncology, biology, physics 2020 Jan . Lee Eunkyung, Eum Sung Y, Slifer Susan H, Martin Eden R, Takita Cristiane, Wright Jean L, Hines Robert B, Hu Jennifer |
Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer. Pathology, research and practice 2020 Dec 217 153309. Kumari Niraj, Singh Rajneesh K, Mishra Shravan K, L Raghvendra, Mohindra Samir, Krishnani Narend |
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens. American journal of clinical oncology 2020 Dec . Marks Eric I, Matera Robert, Olszewski Adam J, Yakirevich Evgeny, El-Deiry Wafik S, Safran Howard, Carneiro Benedito |
Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. Cancers 2021 Jun 13 (12): . Li Wenjing, Amei Amei, Bui Francis, Norouzifar Saba, Lu Lingeng, Wang Zuohe |
Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival. International journal of cancer 2021 May . Mu Rui, Liu Hongliang, Luo Sheng, Patz Edward F, Glass Carolyn, Su Li, Du Mulong, Christiani David C, Jin Lei, Wei Qing |
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. Science translational medicine 2021 1 13 (578): . Tlemsani Camille, Takahashi Nobuyuki, Pongor Lorinc, Rajapakse Vinodh N, Tyagi Manoj, Wen Xinyu, Fasaye Grace-Ann, Schmidt Keith T, Desai Parth, Kim Chul, Rajan Arun, Swift Shannon, Sciuto Linda, Vilimas Rasa, Webb Santhana, Nichols Samantha, Figg William Douglas, Pommier Yves, Calzone Kathleen, Steinberg Seth M, Wei Jun S, Guha Udayan, Turner Clesson E, Khan Javed, Thomas Ani |
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. Journal of the National Cancer Institute 2022 May . Gabriel Aurélie A G, Atkins Joshua R, Penha Ricardo C C, Smith-Byrne Karl, Gaborieau Valerie, Voegele Catherine, Abedi-Ardekani Behnoush, Milojevic Maja, Olaso Robert, Meyer Vincent, Boland Anne, Deleuze Jean François, Zaridze David, Mukeriya Anush, Swiatkowska Beata, Janout Vladimir, Schejbalová Miriam, Mates Dana, Stojši? Jelena, Ognjanovic Miodrag, , Witte John S, Rashkin Sara R, Kachuri Linda, Hung Rayjean J, Kar Siddhartha, Brennan Paul, Sertier Anne-Sophie, Ferrari Anthony, Viari Alain, Johansson Mattias, Amos Christopher I, Foll Matthieu, McKay James |
Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes. BioMed research international 2022 12 2022 4909544. Dong Rui, Chen Shuran, Lu Fei, Zheng Ni, Peng Guisen, Li Yan, Yang Pan, Wen Hexin, Qiu Quanwei, Wang Yitong, Wu Huazhang, Liu Mul |
An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas. Cancer biomarkers : section A of Disease markers 2022 10 36 (1): 31-52. Gupta Amit Kumar, Kumar Man |
Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS. Cancer treatment and research communications 2022 Apr 32 100569. Cannon Timothy Lewis, Randall Jamie N, Sokol Ethan S, Alexander Sonja M, Wadlow Raymond C, Winer Arthur A, Barnett Daniel M, Rayes Danny L, Nimeiri Halla S, McGregor Kimberly |
Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. Thoracic cancer 2023 9 . Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wa |
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic oncology 2023 8 177 14-19. Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giunto |
The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study. Medical archives (Sarajevo, Bosnia and Herzegovina) 2023 3 77 (1): 8-12. Alorjani Mohammed, Aburub Manar, Al-Trad Bahaa, Hamad Mohammad Al, AbuAlarja Manal, Bashir Samir Al, Al-Batayneh Khalid, Zoubi Mazhar |
The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles. Oncotarget 2023 2 14 111-125. Chevarin Martin, Alcantara Diana, Albuisson Juliette, Collonge-Rame Marie-Agnès, Populaire Céline, Selmani Zohair, Baurand Amandine, Sawka Caroline, Bertolone Geoffrey, Callier Patrick, Duffourd Yannis, Jonveaux Philippe, Bignon Yves-Jean, Coupier Isabelle, Cornelis François, Cordier Christophe, Mozelle-Nivoix Monique, Rivière Jean-Baptiste, Kuentz Paul, Thauvin Christel, Boidot Romain, Ghiringhelli François, O'Driscoll Marc, Faivre Laurence, Nambot Soph |
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human genomics 2023 1 17 (1): 2. Kim Jinyong, Jeong Kyeonghun, Jun Hyeji, Kim Kwangsoo, Bae Jeong Mo, Song Myung Geun, Yi Hanbaek, Park Songyi, Woo Go-Un, Lee Dae-Won, Kim Tae-Yong, Lee Kyung-Hun, Im Seock- |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: